Caraceni, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 2.087
AS - Asia 270
EU - Europa 185
AF - Africa 3
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.549
Nazione #
US - Stati Uniti d'America 2.086
CN - Cina 115
SG - Singapore 95
IT - Italia 63
SE - Svezia 37
VN - Vietnam 37
FI - Finlandia 18
DE - Germania 15
FR - Francia 14
IN - India 11
RU - Federazione Russa 11
HK - Hong Kong 9
DK - Danimarca 7
GB - Regno Unito 7
BE - Belgio 5
EG - Egitto 3
UA - Ucraina 3
BR - Brasile 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
AT - Austria 1
CA - Canada 1
EU - Europa 1
LT - Lituania 1
NL - Olanda 1
PE - Perù 1
TR - Turchia 1
Totale 2.549
Città #
Fairfield 414
Woodbridge 231
Chandler 187
Ashburn 175
Houston 161
Cambridge 153
Seattle 147
Ann Arbor 113
Wilmington 103
Singapore 68
Boardman 43
San Diego 42
Dong Ket 37
Beijing 27
Santa Clara 26
Medford 25
Princeton 25
Padova 24
Des Moines 19
Roxbury 16
Nanjing 14
Helsinki 12
Hong Kong 9
Falls Church 8
Shanghai 8
Changsha 7
Rome 7
Guangzhou 6
Hebei 6
Salerno 6
Shenyang 5
Tappahannock 5
Hefei 4
Lyngby 4
New York 4
Tianjin 4
Zhengzhou 4
Aarhus 3
Antwerp 3
Ketsch 3
Kharkiv 3
Milan 3
Alexandria 2
Banská Štiavnica 2
Brussels 2
Dearborn 2
Jinan 2
Kunming 2
London 2
Los Angeles 2
Makati City 2
Nanchang 2
Ningbo 2
Nuremberg 2
Pavia 2
Saint-Fons 2
Shimla 2
Washington 2
Absecon 1
Amsterdam 1
Augusta 1
Bari 1
Bonndorf 1
Bordeaux 1
Borås 1
Cairo 1
Dallas 1
Dongguan 1
Esslingen am Neckar 1
Fabriano 1
Florianópolis 1
Frankfurt am Main 1
Geislingen an der Steige 1
Haikou 1
Hounslow 1
Kilburn 1
Lima 1
Macerata 1
Munich 1
North York 1
Piacenza 1
Pune 1
Rockville 1
San Giorgio di Piano 1
Shenzhen 1
Stockholm 1
Taizhou 1
Venezia 1
Wandsworth 1
Yenibosna 1
Totale 2.228
Nome #
Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial 163
Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections 160
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 156
Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis 138
Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide 122
Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure 120
Strategies to Restore Adenosine Triphosphate (ATP) Level After More than 20 Hours of Cold Ischemia Time in Human Marginal Kidney Grafts 111
The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure 107
Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure 107
AISF-SIMTI Position Paper: The appropriate use of albumin in patients with liver cirrhosis 107
Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe 105
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study 103
AISF-SIMTI position paper: The appropriate use of albumin in patients with liver cirrhosis 97
Specific issues concerning the management of patients on the waiting list and after liver transplantation 97
A Prospective Multicentre Study of the Epidemiology and Outcomes of Bloodstream Infection in Cirrhotic Patients 97
The Italian compassionate use of sofosbuvir in HCV patients waitlisted for liver transplantation: A national real-life experience 96
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 95
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 90
Successful Treatment of CCL4-Induced Acute Liver Failure With Portal Vein Arterialization in the Rat 88
Protective Effect of Portal Vein Arterialization in Acute Liver Failure Induced by Hepatectomy in Normal and Fatty Liver Rat 87
Portal Vein Arterialization for the Treatment of Post Resection Acute Liver Failure in the Rat 78
Risk factors for candidemia in hospitalized patients with liver cirrhosis: a multicenter case-control-control study 76
Development and Validation of a Scoring System That Includes Corrected QT Interval For Risk Analysis of Patients With Cirrhosis and Gastrointestinal Bleeding 71
Technical Aspects of Portal Vein Arterialization for Acute Liver Failure: From Rat Lab to Man 68
ENDPOINTS AND DESIGN OF CLINICAL TRIALS IN PATIENTS WITH DECOMPENSATED CIRRHOSIS: POSITION PAPER OF THE LIVERHOPE CONSORTIUM 46
Totale 2.585
Categoria #
all - tutte 9.691
article - articoli 9.691
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.382


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020236 0 0 0 0 0 0 0 63 66 48 52 7
2020/2021500 24 14 20 24 16 32 11 63 50 83 76 87
2021/2022429 19 92 37 10 37 23 37 31 15 15 33 80
2022/2023316 67 40 4 45 46 36 1 16 37 1 17 6
2023/2024143 5 23 19 17 3 21 16 4 0 10 14 11
2024/2025227 1 40 26 43 62 30 21 4 0 0 0 0
Totale 2.585